Acute neural effects of selective serotonin reuptake inhibitors versus noradrenaline reuptake inhibitors on emotion processing: Implications for differential treatment efficacy

Imagem de Miniatura
Arquivos
art_KEMP_Acute_neural_effects_of_selective_serotonin_reuptake_inhibitors_2013.PDF (2.02 MB)
Citações na Scopus
64
Tipo de produção
article
Data de publicação
2013
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
PERGAMON-ELSEVIER SCIENCE LTD
Autores
OUTHRED, Tim
HAWKSHEAD, Brittany E.
WAGER, Tor D.
DAS, Pritha
MALHI, Gin S.
Citação
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, v.37, n.8, p.1786-1800, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Clinical research has demonstrated differential efficacy of selective serotonin reuptake inhibitors (SSRIs) and norepinephrine reuptake inhibitors (NRIs), which may relate to differential acute effects these medications have on emotional brain processes. Here we present findings from a Multi-Level Kernel Density Analysis meta-analysis that integrates and contrasts activations from disparate fMRI studies in order to examine whether single dose SSRIs and NRIs have different effects on emotion processing tasks in healthy participants. Seven SSRI and four NRI studies were eligible for inclusion. SSRIs decreased amygdala responses, suggesting reduced emotional reactivity to emotional stimuli, whereas NRIs increased frontal and medial activation, suggesting increased emotion regulation. As hypothesised, an interaction of antidepressant and task type was found, such that SSRIs modulated amygdaloid-hippocampal, medial and frontal activity during both the presentation of faces and pictures, whereas NRIs only modulated the activation in medial and frontal regions during the presentation of pictures. Findings are interpreted within a novel model of the differential effects of SSRIs and NRIs on emotion processing.
Palavras-chave
Antidepressants, SSRI, NRI, Serotonin, Noradrenalin, Emotion, fMRI, Multi-Level Kernel Density Analysis Meta-analysis
URI
https://observatorio.fm.usp.br/handle/OPI/4642
Referências
  1. Amiez C, 2012, NEUROIMAGE, V63, P1078, DOI 10.1016/j.neuroimage.2012.06.023
  2. Anderson IM, 2007, NEUROREPORT, V18, P1351, DOI 10.1097/WNR.0b013e3282742115
  3. Arce E, 2008, PSYCHOPHARMACOLOGY, V196, P661, DOI 10.1007/s00213-007-1004-8
  4. Arnone D, 2012, AM J PSYCHIAT, V169, P841, DOI 10.1176/appi.ajp.2012.11121774
  5. Balderston NL, 2011, NEUROIMAGE, V55, P1889, DOI 10.1016/j.neuroimage.2011.01.034
  6. Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029
  7. Beck A. T., 1979, COGNITIVE THERAPY DE
  8. Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721
  9. Bellani M, 2010, EPIDEMIOL PSICHIAT S, V19, P298
  10. Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1056/NEJMra073096
  11. Bigler ED, 2007, DEV NEUROPSYCHOL, V31, P217
  12. Bigos KL, 2008, NEUROPSYCHOPHARMACOL, V33, P3221, DOI 10.1038/npp.2008.52
  13. Blair KS, 2012, BIOL PSYCHIAT, V72, P476, DOI 10.1016/j.biopsych.2012.04.013
  14. Bleich-Cohen M, 2006, NEUROREPORT, V17, P1391, DOI 10.1097/01.wnr.0000215772.68979.f4
  15. Blier P, 2001, J PSYCHIATR NEUROSCI, V26, pS3
  16. Bonisch H, 2006, HANDB EXP PHARM, V175, P485
  17. Britton JC, 2006, NEUROIMAGE, V31, P397, DOI 10.1016/j.neuroimage.2005.11.027
  18. Britton JC, 2006, NEUROIMAGE, V31, P906, DOI 10.1016/j.neuroimage.2005.12.050
  19. Brooks SJ, 2012, NEUROIMAGE, V59, P2962, DOI 10.1016/j.neuroimage.2011.09.077
  20. Bruhl AB, 2011, PSYCHOPHARMACOLOGY, V216, P389, DOI 10.1007/s00213-011-2227-2
  21. Bruhl AB, 2010, NEUROPSYCHOPHARMACOL, V35, P521, DOI 10.1038/npp.2009.159
  22. Brunello N, 2003, INT CLIN PSYCHOPHARM, V18, P191, DOI 10.1097/01.yic.0000073880.93678.68
  23. BUNNEY WE, 1965, ARCH GEN PSYCHIAT, V13, P483
  24. Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2
  25. Castren E, 2004, CURR OPIN PHARMACOL, V4, P58, DOI 10.1016/j.coph.2003.10.004
  26. Cipriani A, 2012, COCHRANE DB SYST REV, V7
  27. Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5
  28. Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555
  29. Davidson R.J., 2012, EMOTIONAL LIFE YOUR, P67
  30. Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2
  31. Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148
  32. Delaveau P, 2011, J AFFECT DISORDERS, V130, P66, DOI 10.1016/j.jad.2010.09.032
  33. Del-Ben CM, 2005, NEUROPSYCHOPHARMACOL, V30, P1724, DOI 10.1038/sj.npp.1300728
  34. den Heijer T, 2012, NEUROIMAGE, V63, P1782, DOI 10.1016/j.neuroimage.2012.08.067
  35. Denny BT, 2012, J COGNITIVE NEUROSCI, V24, P1742, DOI 10.1162/jocn_a_00233
  36. Depue R A, 1986, Ann N Y Acad Sci, V487, P47, DOI 10.1111/j.1749-6632.1986.tb27885.x
  37. Di Simplicio M., 2011, MOL PSYCHIATR, V17, P503
  38. Dominguez-Borras J, 2009, CEREB CORTEX, V19, P1521, DOI 10.1093/cercor/bhn188
  39. Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013
  40. Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biophysc.2004.02.033
  41. Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504
  42. Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004
  43. Eyding D., 2010, BMJ 0617, V341, P4737
  44. First M., 2012, J MOL NEUROSCI, P1
  45. Frank MG, 2001, J PERS SOC PSYCHOL, V80, P75, DOI 10.1037//0022-3514.80.1.75
  46. Frankenstein U, 2003, CONCEPTS MAGN RESO A, V16A, P63, DOI 10.1002/cmr.a.10054
  47. Gillespie C.F., 2011, AM PSYCHIAT PUBLISHI
  48. Godlewska B.R., 2012, PSYCHOL MED, V42, P1
  49. Grimm S, 2006, NEUROIMAGE, V30, P325, DOI 10.1016/j.neuroimage.2005.09.006
  50. Gross J., 2007, HDB EMOTION REGULATI, V50, P3
  51. Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037//0022-3514.74.1.224
  52. Haenisch B, 2011, PHARMACOL THERAPEUT, V129, P352, DOI 10.1016/j.pharmthera.2010.12.002
  53. Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179
  54. Harmer CJ, 2006, BIOL PSYCHIAT, V59, P816, DOI 10.1016/j.biopsych.2005.10.015
  55. Harmer CJ, 2011, J PSYCHOPHARMACOL, V25, P1148, DOI 10.1177/0269881110367722
  56. Harmer CJ, 2004, AM J PSYCHIAT, V161, P1256, DOI 10.1176/appi.ajp.161.7.1256
  57. Harmer CJ, 2009, BRIT J PSYCHIAT, V195, P102, DOI 10.1192/bjp.bp.108.051193
  58. Harmer CJ, 2009, AM J PSYCHIAT, V166, P1178, DOI 10.1176/appi.ajp.2009.09020149
  59. Harmer C.J., 2012, CURRENT TOPICS BEHAV, V14, P209
  60. Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1
  61. Hyman SE, 1996, AM J PSYCHIAT, V153, P151
  62. Jung YC, 2008, BRAIN RES, V1246, P136, DOI 10.1016/j.brainres.2008.09.081
  63. Keedwell PA, 2005, BIOL PSYCHIAT, V58, P495, DOI 10.1016/j.biopsych.2005.04.035
  64. Kemp A.H., 2008, CNS SPECTRUMS, V13, P1087
  65. Kemp A.H., 2013, HDB AFFECTIVE COMPUT
  66. Kemp AH, 2008, CNS SPECTRUMS, V13, P1066
  67. Kemp AH, 2004, INT J NEUROPSYCHOPH, V7, P65, DOI 10.1017/S1461145703003891
  68. Kemp AH, 2004, NEUROIMAGE, V22, P1084, DOI 10.1016/j.neuroimage.2004.03.022
  69. Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617
  70. Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059
  71. Kober H, 2010, WIRES COGN SCI, V1, P293, DOI 10.1002/wcs.41
  72. Korb AS, 2011, PSYCHIAT RES-NEUROIM, V192, P188, DOI 10.1016/j.pscychresns.2010.12.007
  73. Kukolja J, 2008, J NEUROSCI, V28, P12868, DOI 10.1523/JNEUROSCI.3592-08.2008
  74. LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x
  75. LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005
  76. Lee H, 2012, NEUROIMAGE, V62, P1575, DOI 10.1016/j.neuroimage.2012.05.044
  77. Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446
  78. Luo Q, 2010, J NEUROSCI, V30, P5825, DOI 10.1523/JNEUROSCI.BC-5668-09.2010
  79. MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107
  80. Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960
  81. Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471
  82. Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/ldg65.193
  83. Mayberg HS, 2007, BIOL PSYCHIAT, V61, P729, DOI 10.1016/j.biopsych.2007.01.013
  84. McCabe C, 2011, NEUROIMAGE, V57, P1317, DOI 10.1016/j.neuroimage.2011.05.051
  85. Miskowiak K, 2007, NEUROIMAGE, V37, P904, DOI 10.1016/j.neuroimage.2007.05.036
  86. Montgomery SA, 1997, J PSYCHOPHARMACOL, V11, pS9
  87. Murphy SE, 2009, BRIT J PSYCHIAT, V194, P535, DOI 10.1192/bjp.bp.108.056093
  88. Murphy SE, 2009, INT J NEUROPSYCHOPH, V12, P169, DOI 10.1017/S1461145708009164
  89. Norbury R, 2007, BRIT J PSYCHIAT, V190, P531, DOI 10.1192/bjp.bp.106.031393
  90. Norbury R., 2007, MOL PSYCHIATR, V13, P1011
  91. Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010
  92. Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x
  93. Onur OA, 2009, SOC COGN AFFECT NEUR, V4, P119, DOI 10.1093/scan/nsn049
  94. Papadatou-Pastou M, 2012, EXP CLIN PSYCHOPHARM, V20, P364, DOI 10.1037/a0027969
  95. Patin A, 2011, NEUROPSYCHOLOGIA, V49, P706, DOI 10.1016/j.neuropsychologia.2010.10.004
  96. Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042
  97. Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025
  98. Pitychoutis PM, 2012, NEUROSCIENCE, V210, P152, DOI 10.1016/j.neuroscience.2012.03.003
  99. Pizzagalli DA, 2011, NEUROPSYCHOPHARMACOL, V36, P183, DOI 10.1038/npp.2010.166
  100. Pourtois G, 2010, COGN AFFECT BEHAV NE, V10, P83, DOI 10.3758/CABN.10.1.83
  101. Pringle A, 2011, PROG NEURO-PSYCHOPH, V35, P1586, DOI 10.1016/j.pnpbp.2010.07.022
  102. Radua J., 2012, BIOL MOOD ANX DIS, V2, P1
  103. Rawlings NB, 2010, PSYCHOPHARMACOLOGY, V212, P625, DOI 10.1007/s00213-010-1983-8
  104. Roiser JP, 2012, NEUROPSYCHOPHARMACOL, V37, P117, DOI 10.1038/npp.2011.183
  105. Roseboom P.H., 2011, AM PSYCHIAT PUBLISHI, P363
  106. Scherer K.R., 2000, NEUROPSYCHOLOGY EMOT, P137
  107. SCHILDKRAUT JJ, 1965, AM J PSYCHIAT, V122, P509
  108. Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015
  109. Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X
  110. Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048
  111. Stahl SM, 1998, J AFFECT DISORDERS, V51, P215, DOI 10.1016/S0165-0327(98)00221-3
  112. Takahashi H, 2005, NEUROIMAGE, V27, P991, DOI 10.1016/j.neuroimage.2005.05.039
  113. Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28
  114. Turk-Browne N.B., 2010, FRONT HUM NEUROSCI, V4, P176
  115. Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x
  116. Vytal K, 2010, J COGNITIVE NEUROSCI, V22, P2864, DOI 10.1162/jocn.2009.21366
  117. Wager T.D., 2008, MULTILEVEL KERNEL DE
  118. Wager TD, 2009, NEUROIMAGE, V45, pS210, DOI 10.1016/j.neuroimage.2008.10.061
  119. Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006
  120. Wager T.D., 2010, HDB EMOTIONS
  121. Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156
  122. Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3
  123. Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257

Coleções
Artigos e Materiais de Revistas Científicas - HU